SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $427 | -3.6% | 15,470 | +4.9% | 0.00% | 0.0% |
Q2 2023 | $443 | -26.5% | 14,752 | -11.4% | 0.00% | -25.0% |
Q1 2023 | $603 | +114.6% | 16,653 | +111.3% | 0.00% | +100.0% |
Q4 2022 | $281 | -100.0% | 7,881 | -74.3% | 0.00% | -75.0% |
Q3 2022 | $1,037,000 | +305.1% | 30,624 | +245.7% | 0.01% | +300.0% |
Q2 2022 | $256,000 | -28.9% | 8,859 | -20.4% | 0.00% | 0.0% |
Q1 2022 | $360,000 | +21.6% | 11,136 | +9.6% | 0.00% | +100.0% |
Q4 2021 | $296,000 | +31.0% | 10,163 | +19.7% | 0.00% | 0.0% |
Q3 2021 | $226,000 | +6.1% | 8,491 | +22.5% | 0.00% | 0.0% |
Q2 2021 | $213,000 | -30.6% | 6,930 | +13.7% | 0.00% | -50.0% |
Q3 2018 | $307,000 | -50.7% | 6,096 | -41.4% | 0.00% | -50.0% |
Q2 2018 | $623,000 | +19.8% | 10,406 | -8.3% | 0.00% | +33.3% |
Q1 2018 | $520,000 | -25.2% | 11,344 | -34.9% | 0.00% | -40.0% |
Q4 2017 | $695,000 | +526.1% | 17,438 | +218.9% | 0.01% | +400.0% |
Q2 2016 | $111,000 | +73.4% | 5,468 | +29.6% | 0.00% | – |
Q1 2016 | $64,000 | +48.8% | 4,219 | +31.4% | 0.00% | – |
Q4 2015 | $43,000 | -25.9% | 3,210 | -21.7% | 0.00% | – |
Q3 2015 | $58,000 | +163.6% | 4,099 | +221.7% | 0.00% | – |
Q2 2015 | $22,000 | – | 1,274 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |